- Cellect Biotechnology Ltd. APOP shares surged 24.7 percent to $5.20. Cellect Biotech disclosed that it has treated the first blood cancer patient in Phase I/II trial of ApoGraft
- Kforce Inc. KFRC shares climbed 21.1 percent to $25.85 after the company reported better-than-expected Q4 earnings. Avondale Partners upgraded Kforce from Market Perform to Outperform.
- Wecast Network Inc WCST shares rose 20.4 percent to $1.91.
- Aehr Test Systems AEHR surged 18.6 percent to $2.62 as the company disclosed that it has received an order from a subcontractor to its lead customer for its FOX-XP test and burn-in system products.
- Coherent, Inc. COHR shares climbed 17.5 percent to $189.63 after the company reported better-than-expected Q1 earnings.
- Lumentum Holdings Inc LITE jumped 14.9 percent to $46.18 on better-than-expected quarterly earnings.
- Diffusion Pharmaceuticals Inc DFFN shares surged 14.8 percent to $5.03. Diffusion Pharmaceuticals disclosed that TSC Phase 1/2 glioblastoma multiforme clinical trial results has been published in the February 2017 edition of Journal of Neurosurgery.
- Foundation Medicine Inc FMI shares climbed 13.1 percent to $24.77 in pre-market trading after surging 12.31 percent on Tuesday. Foundation Medicine will release its quarterly earnings on February 22, 2017.
- Caesarstone Ltd CSTE gained 12.7 percent to $33.80. Caesarstone reported Q4 adjusted earnings of $0.53 per share on revenue of $135 million.
- Universal Corp UVV climbed 12 percent to $78.90. Universal Corp reported FQ3 net income of $53.6 million on revenue of $668.8 million.
- OncoSec Medical Inc ONCS rose 11.7 percent to $1.32. OncoSec disclosed that it will present new clinical data from its Phase 2 combination study at ASCO-SITC Clinical Immuno-Oncology Symposium.
- Jive Software Inc JIVE gained 10.8 percent to $4.38 after the company posted upbeat quarterly results.
- Walker & Dunlop, Inc. WD shares surged 10.6 percent to $35.50 after the company posted strong Q4 results.
- Myriad Genetics, Inc. MYGN gained 10.6 percent to $17.03 after the company posted upbeat Q2 results and narrowed its FY17 adjusted earnings outlook. Ladenburg Thalmann upgraded Myriad Genetics from Sell to Neutral.
- ScanSource, Inc. SCSC shares climbed 10 percent to $44.08 on stronger-than-expected quarterl
- y earnings.
- Microchip Technology Inc. MCHP rose 7.6 percent to $74.90 after the company reported upbeat Q3 results and issued a strong Q4 outlook. Needham upgraded Microchip from Buy to Strong Buy.
- Momo Inc (ADR) MOMO gained 7.5 percent to $24.48. Jefferies initiated coverage of Momo with a Buy rating.
- Thor Industries, Inc. THO rose 4.7 percent to $109.38. Baird upgraded Thor Industries from Neutral to Outperform.
- Vanda Pharmaceuticals Inc. VNDA rose 4.1 percent to $14.20. Vanda Pharmaceuticals is expected to announce Q4 financial results on February 15, 2017.
- Cognizant Technology Solutions Corp CTSH shares rose 3.7 percent to $55.76 after the company posted upbeat quarterly earnings and reported a cooperation agreement with Elliott Management.
COHRCoherent Corp
$99.780.77%
CSTECaesarstone Ltd
$4.42-%
CTSHCognizant Technology Solutions Corp
$79.490.62%
JIVEJPMorgan International Value ETF
$55.40-1.76%
KFRCKforce Inc
$56.07-%
LITELumentum Holdings Inc
$84.341.35%
MCHPMicrochip Technology Inc
$58.521.12%
MOMOHello Group Inc
$7.39-%
MYGNMyriad Genetics Inc
$13.740.66%
SCSCScanSource Inc
$48.571.17%
THOThor Industries Inc
$97.891.51%
UVVUniversal Corp
$54.800.68%
VNDAVanda Pharmaceuticals Inc
$4.833.21%
WDWalker & Dunlop Inc
$97.990.63%
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Posted In:
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in